Jose-Miguel Coteron Lopez

Title: Innovations of Jose-Miguel Coteron Lopez

Introduction

Jose-Miguel Coteron Lopez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmacology, particularly in the development of compounds with potential therapeutic applications. His work is recognized for addressing critical health challenges, including parasitic infections.

Latest Patents

Jose-Miguel Coteron Lopez holds a patent for a compound known as (S) and (R)-N-(2-fluoropyridin-4-yl)-3-methyl-2-(5-methyl-2,4-dioxo-1,2-dihydropyrido[3,4-d]pyrimidin-3(4H)-yl)butanamide. This invention relates to a compound of Formula (I) that exhibits pharmacological activity. The patent outlines processes for its preparation, pharmaceutical compositions, and their use in treating certain parasitic protozoal infections, such as malaria.

Career Highlights

Jose-Miguel Coteron Lopez is associated with GlaxoSmithKline Intellectual Property Development Limited, where he has been instrumental in advancing innovative pharmaceutical solutions. His expertise in the field has led to the development of valuable compounds that contribute to public health.

Collaborations

Throughout his career, Jose-Miguel has collaborated with esteemed colleagues, including Esther Pilar Fernandez Velando and Jorge Fernandez-Molina. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jose-Miguel Coteron Lopez exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in combating health challenges. His work continues to inspire future advancements in medical science.